1964 Pilot study of bevacizumab (Bev) in combination with docetaxel (T) and cyclophosphamide (C) as adjuvant treatment (AdjRx) for patients (pts) with early stage (ES) HER-2 normal breast cancer (BrCa) ICORG 08-10. (September 2015)

• Record Type: Journal Article
• Authors: Gullo, G.; Kennedy, J.; Breathnach, O.; McCaffrey, J.; Keane, M.; Martin, M.; Gupta, R.; Leonard, G.; Calvert, P.; Donnellan, P.; Walshe, J.; Mc Dermott, E.; Cairney, S.; Bose, R.; Scott, K.; Hernando, A.; Parker, I.; Tryfonopoulos, D.; Moulton, B.; Crown, J.
• Is Part Of: European journal of cancer. Volume 51:(2015)Supplement 3
• Page Start: S321
• Publication Date: 2015-09
• Subjects: Cancer -- Periodicals; Neoplasms -- Periodicals; Cancer -- Périodiques; Cancer; Tumors; Electronic journals; Periodicals; Electronic journals; 616.994
• DOI: 10.1016/S0959-8049(16)30912-1
• Languages: English
• ISSNs: 0959-8049